title: Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
authors.affiliation: Centre Hospitalier Sainte Marie, Clermont-Ferrand Cedex 1, France Clermont Université, Université d'Auvergne Clermont 1, UFR Médecine, Clermont-Ferrand, France Centre Hospitalier Sainte Marie, Clermont-Ferrand Cedex 1, France Clermont Université Université, d'Auvergne Clermont 1, UFR Médecine, Clermont-Ferrand, France and CHU Clermont-Ferrand, Service de Psychiatrie de l'Adulte A et Psychologie Médicale, Pôle de Psychiatrie Clermont-Ferrand, France ijalenques@chu-clermontferrand.fr.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Legrand
authors.forename: Méja
authors.initials: M
authors.lastname: Andrianarisoa
authors.forename: Joëlle
authors.initials: J
authors.lastname: Mauvieux
authors.forename: Isabelle
authors.initials: I
authors.lastname: Jalenques
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D004351:Drug Resistance; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D000068882:Paliperidone Palmitate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D001569:Benzodiazepines; D000077152:Olanzapine; D000068882:Paliperidone Palmitate